New discoveries about molecular mechanisms of drug response have given a new dimension to the research. In spite of these scientific advances, most cancer treatment decisions still continue to rely on Chemotherapy. Usually, more than one drug is necessary to attack each tumour.
HOW WILL IT WORK:
Taking the CLYZ Cancertain test will be easy and fast. Fresh a Blood sample and Fresh samples from solid or fluid tumours will be obtained from the biopsy or surgery of the patient. Those samples will be sent to the CLYZ Labs to conduct Cancertain Test with a variety of chemotherapy/immunotherapy drugs along with the blood test. Test results will be available in 10 -14 days after the biopsy.
Sensitivity is found by determining the level of effectiveness of certain chemo-agents against cancer cells of the patient. In the opposite way, the results of the chemosensitivity test also determines the drug resistance which means offering information about which cancer cells of the patient continue living and growing despite receiving the drug. With the results of this test, the patients do not need to go through a “guess and check” treatment with the drugs and they can protect their immune system from the beginning of the treatment.
WHO WILL BE ABLE TO TAKE THE TEST:
Eventually, the test will be suitable for any patient diagnosed with cancer at any stage of the disease. Those who take the test before starting the first treatment will benefit most.
BENEFITS AND RECOMMENDED TREATMENT
Results of the CLYZ Cancertain test will offer a new approach to potential chemotherapy treatments. A wide combination of drugs and medicines will no longer be necessary and side effects of non-beneficial drugs will be avoided. The quality of life will improve during the treatment and after completing it because of the lower amount of drugs required.